Evidence map›Paper›PMID 30453671›Full record

ArticleJournal of clinical medicine2018

Predictors of Exercise Capacity in Patients with Hypertrophic Obstructive Cardiomyopathy.

Joshua R Smith, Jose R Medina-Inojosa, Veronica Layrisse, Steve R Ommen, Thomas P Olson

Abstract read
In one paragraph

Article in Journal of clinical medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Observational
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Joshua R SmithDivision of Preventive Cardiology, Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN 55095, USA. smith.joshua1@mayo.edu.ORCID 0000-0002-3687-6261
Jose R Medina-InojosaDivision of Preventive Cardiology, Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN 55095, USA. medinaInojosa.jose@mayo.edu.ORCID 0000-0001-8705-0462
Veronica LayrisseDivision of Preventive Cardiology, Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN 55095, USA. veronicall@sanjuanbautista.edu.
Steve R OmmenDivision of Preventive Cardiology, Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN 55095, USA. ommen.steve@mayo.edu.
Thomas P OlsonDivision of Preventive Cardiology, Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN 55095, USA. olson.thomas2@mayo.edu.

Funding

Institutional Short-Term Research Training for Students of DiversityR25HL092621 · NHLBI · MAYO CLINIC ROCHESTER · PI HORAZDOVSKY, BRUCE F · 2008 to 2023
$2.0M
American Heart Association 18POST3990251American Heart Association-American Stroke Association 18POST33990251Foundation for the National Institutes of Health HL-126638Foundation for the National Institutes of Health R25-HL092621NHLBI NIH HHS R25 HL092621
6 · The paper itself

Abstract

Hypertrophic obstructive cardiomyopathy (HOCM) patients exhibit compromised peak exercise capacity (VO₂peak). Importantly, severely reduced VO₂peak is directly related to increased morbidity and mortality in these patients. Therefore, we sought to determine clinical predictors of VO₂peak in HOCM patients. HOCM patients who performed symptom-limited cardiopulmonary exercise testing between 1995 and 2016 were included for analysis. Peak VO₂ was reported as absolute peak VO₂, indexed to body weight and analyzed as quartiles, with quartile 1 representing the lowest VO₂peak. Step-wise regression models using demographic features and clinical and physiologic characteristics were created to determine predictors of HOCM patients with the lowest VO₂peak. We included 1177 HOCM patients (age: 53 ± 14 years; BMI: 24 ± 12 kg/m²) with a VO₂peak of 18.0 ± 5.6 mL/kg/min. Significant univariate predictors of the lowest VO₂peak included age, female sex, New York Health Association (NYHA) class, BMI, left atrial volume index, E/e', E/A, hemoglobin, N-terminal pro b-type natriuretic peptide (NT-proBNP), and a history of diabetes, hypertension, stroke, atrial fibrillation, or coronary artery disease. Independent predictors of the lowest VO₂peak included age (OR, CI: 1.03, 1.02⁻1.06;

Indexed as

exercise capacityexercise testinghypertrophic cardiomyopathy

Identifiers

PMID30453671
PMCPMC6262545

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.